Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

A Method of Assessment of Tumor Microenvironment Immune Activity


Technology Benefits

The merits of this technology represent an advantageous opportunity to stratify patients with regard to prognoses and with regard to the value of immunotherapies.


Detailed Technology Description

Using the Cancer Genome Atlas (TCGA), gene expression data was analyzed to determine the immune function signature of an isolated cancer sample. Such signatures were found to provide a basis for correlations with prognosis or for moreconvenient indications of treatment options. This type of data can potentially indicate the extent of an anti-tumor immune response or tumor infiltrating lymphocytes (TILs) could be available for further exvivo amplification and subsequent therapy. The merits of this technology represent an advantageous opportunity to stratify patients with regard toprognoses and with regard to the value of immunotherapies.


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View